Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment
- PMID: 20973856
- PMCID: PMC3017215
- DOI: 10.1111/j.1360-0443.2010.03173.x
Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment
Abstract
Aims: To understand the relations among anxiety disorders and tobacco dependence, withdrawal symptoms, response to smoking cessation pharmacotherapy and ability to quit smoking.
Design: Randomized placebo-controlled clinical trial. Participants received six 10-minute individual counseling sessions and either: placebo, bupropion SR, nicotine patch, nicotine lozenge, bupropion SR + nicotine lozenge or nicotine patch + nicotine lozenge.
Setting: Two urban research sites.
Participants: Data were collected from 1504 daily smokers (>9 cigarettes per day) who were motivated to quit smoking and did not report current diagnoses of schizophrenia or psychosis or bupropion use.
Measurements: Participants completed baseline assessments, the Composite International Diagnostic Interview and ecological momentary assessments for 2 weeks.
Findings: A structured clinical interview identified participants who ever met criteria for a panic attack (n = 455), social anxiety (n = 199) or generalized anxiety disorder (n = 99), and those who qualified for no anxiety diagnosis (n = 891). Smokers with anxiety disorders reported higher levels of nicotine dependence and pre-quit withdrawal symptoms. Those ever meeting criteria for panic attacks or social anxiety disorder showed greater quit-day negative affect. Smokers ever meeting criteria for anxiety disorders were less likely to be abstinent at 8 weeks and 6 months post-quit and showed no benefit from single-agent or combination-agent pharmacotherapies.
Conclusions: Anxiety diagnoses were common among treatment-seeking smokers and were related to increased motivation to smoke, elevated withdrawal, lack of response to pharmacotherapy and impaired ability to quit smoking. These findings could guide treatment assignment algorithms and treatment development for smokers with anxiety diagnoses.
© 2010 The Authors, Addiction © 2010 Society for the Study of Addiction.
Conflict of interest statement
Disclosures: Megan E. Piper, Jessica W. Cook, and Tanya R. Schlam have no potential conflicts of interest to disclose.
Figures
References
-
- Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry. 2004 Nov;61(11):1107–1115. - PubMed
-
- Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: A population-based prevalence study. JAMA. 2000 Nov 22–29;284(20):2606–2610. - PubMed
-
- Dani JA, Harris RA. Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nat. Neurosci. 2005 Nov;8(11):1465–1470. - PubMed
-
- Snyder M. Serious mental illness and smoking cessation. Issues Ment. Health Nurs. 2006 Jul;27(6):635–645. - PubMed
-
- Ziedonis D, Williams JM, Smelson D. Serious mental illness and tobacco addiction: A model program to address this common but neglected issue. Am. J. Med. Sci. 2003 Oct;326(4):223–230. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
